Back to search

Article

Analysis of hepatic lentiviral vector transduction; implications for preclinical studies and clinical gene therapy protocols

2024-08-21

Abstract excerpt

Lentiviral vector-transduced T-cells were approved by the FDA as gene therapy anti-cancer medications. Little is known about the host genetic variation effects on the safety and efficacy of the lentiviral vector gene delivery system. To narrow this knowledge-gap, we characterized hepatic gene delivery by lentiviral vectors across the Collaborative Cross (CC) mouse genetic reference population. For 24 weeks, we per...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
119ebdaf-42ed-505d-b1bf-a960a85dfab5
DOI
10.1101/2024.08.20.608805
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Analysis of hepatic lentiviral vector transduction; implications for preclinical studies and clinical gene therapy protocolsDOI 10.1101/2024.08.20.608805
Select a neighboring publication to make it the new centre.